103 related articles for article (PubMed ID: 1966950)
1. Pemphigus and pemphigoid epidermocytes interfere with interleukin cascade reactions.
Grando SA; Glukhenky BT; Drannik GN; Kostromin AP; Chernyavsky AI; Barabash TM
J Clin Lab Immunol; 1990 Jul; 32(3):137-41. PubMed ID: 1966950
[TBL] [Abstract][Full Text] [Related]
2. [Disorders of interleukin cascade reactions in pemphigus and pemphigoid and methods for their correction].
Grando SA
Vestn Dermatol Venerol; 1989; (9):10-3. PubMed ID: 2692341
[TBL] [Abstract][Full Text] [Related]
3. The effect of experimental haemocarbofiltration upon activity of mononuclear cells from normal and autoimmune patients.
Grando SA; Glukhenky BT; Drannik GN; Kostromin AP; Romanenko AB
Immunology; 1989 Jan; 66(1):138-42. PubMed ID: 15493276
[TBL] [Abstract][Full Text] [Related]
4. Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid.
Grando SA; Glukhenky BT; Drannik GN; Epshtein EV; Kostromin AP; Korostash TA
Arch Dermatol; 1989 Jul; 125(7):925-30. PubMed ID: 2662908
[TBL] [Abstract][Full Text] [Related]
5. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.
Bhol KC; Rojas AI; Khan IU; Ahmed AR
Cytokine; 2000 Jul; 12(7):1076-83. PubMed ID: 10880254
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris.
Asashima N; Fujimoto M; Watanabe R; Nakashima H; Yazawa N; Okochi H; Tamaki K
Br J Dermatol; 2006 Aug; 155(2):330-6. PubMed ID: 16882171
[TBL] [Abstract][Full Text] [Related]
7. Interleukin cascade reaction inhibition by supernatants of the cultures of antibody-transformed human basal keratinocytes.
Grando SA; Drannik GN; Glukhenky BT; Boiko YuYa ; Kostromin AP; Chernyavsky AI
Immunol Invest; 1988; 17(6-7):567-76. PubMed ID: 2466782
[TBL] [Abstract][Full Text] [Related]
8. Searching for foreign antigens as possible triggering factors of autoimmunity: Torque Teno virus DNA prevalence is elevated in sera of patients with bullous pemphigoid.
Blazsek A; Sillo P; Ishii N; Gergely P; Poor G; Preisz K; Hashimoto T; Medvecz M; Kárpáti S
Exp Dermatol; 2008 May; 17(5):446-54. PubMed ID: 18400063
[TBL] [Abstract][Full Text] [Related]
9. Autoreactive cytotoxic T lymphocytes in pemphigus and pemphigoid.
Grando SA; Glukhenky BT; Drannik GN; Kostromin AP; Boiko YYa ; Senyuk OF
Autoimmunity; 1989; 3(4):247-60. PubMed ID: 2491630
[TBL] [Abstract][Full Text] [Related]
10. The desmosome and hemidesmosome in cutaneous autoimmunity.
Lin MS; Mascaró JM; Liu Z; España A; Diaz LA
Clin Exp Immunol; 1997 Jan; 107 Suppl 1():9-15. PubMed ID: 9020929
[TBL] [Abstract][Full Text] [Related]
11. Stimulating effect of pemphigus antibodies upon interleukin inhibitor production by normal human epidermocytes.
Grando SA; Drannik GN; Kostromin AP; Glukhenky BT; Chernyavsky AI; Korostash TA
Immunol Invest; 1989; 18(9-10):1107-20. PubMed ID: 2613287
[TBL] [Abstract][Full Text] [Related]
12. Normalization of defective interleukin 1 and interleukin 2 production in patients with pemphigus vulgaris following chrysotherapy.
Blitstein-Willinger E
Clin Exp Immunol; 1985 Dec; 62(3):705-14. PubMed ID: 3936658
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid.
Frezzolini A; Teofoli P; Cianchini G; Barduagni S; Ruffelli M; Ferranti G; Puddu P; De Pita O
Eur J Dermatol; 2002; 12(1):27-31. PubMed ID: 11809592
[TBL] [Abstract][Full Text] [Related]
14. Lesional Th17 cells and regulatory T cells in bullous pemphigoid.
Arakawa M; Dainichi T; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Tsuruta D; Hashimoto T
Exp Dermatol; 2011 Dec; 20(12):1022-4. PubMed ID: 22017210
[TBL] [Abstract][Full Text] [Related]
15. A possible interaction between periostin and CD163
Fujimura T; Kakizaki A; Furudate S; Aiba S
Exp Dermatol; 2017 Dec; 26(12):1193-1198. PubMed ID: 27501402
[TBL] [Abstract][Full Text] [Related]
16. [Bullous pemphigoid with pemphigus type antibodies in vivo. 2 cases].
Bernard P; Catanzano G; Vignaud St Florent JD; Fayol J; Bonnetblanc JM
Ann Dermatol Venereol; 1986; 113(8):671-6. PubMed ID: 3541760
[TBL] [Abstract][Full Text] [Related]
17. Identification of different circulating autoantibodies in patients with bullous pemphigoid and pemphigus vulgaris by means of immunoblotting.
Kiss M; Husz S; Molnár K; Dobozy A
Acta Microbiol Immunol Hung; 1996; 43(2-3):115-23. PubMed ID: 8876727
[TBL] [Abstract][Full Text] [Related]
18. The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients.
Frusic-Zlotkin M; Pergamentz R; Michel B; David M; Mimouni D; Brégégère F; Milner Y
Ann N Y Acad Sci; 2005 Jun; 1050():371-9. PubMed ID: 16014554
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic proteases in blister fluid of pemphigus and pemphigoid patients.
Grando SA; Glukhenky BT; Drannik GN; Kostromin AP; Chernyavsky AI
Int J Tissue React; 1989; 11(4):195-201. PubMed ID: 2699467
[TBL] [Abstract][Full Text] [Related]
20. Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris.
Rico MJ; Benning C; Weingart ES; Streilein RD; Hall RP
Br J Dermatol; 1999 Jun; 140(6):1079-86. PubMed ID: 10354074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
